Guiyang Xintian Pharmaceutical Co.,Ltd. (SHE:002873)
China
· Delayed Price · Currency is CNY 8.67
+0.05 (0.58%)
Apr 30, 2025, 3:04 PM CST
SHE:002873 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | 40.94 | 52.32 | 80.87 | 111.52 | 100.61 | 74.1 | Upgrade
|
| Depreciation & Amortization | 37.38 | 37.38 | 22.31 | 25.45 | 22.81 | 19.09 | Upgrade
|
| Other Amortization | 1.61 | 1.61 | 2.51 | 1.28 | 2.69 | 2.15 | Upgrade
|
| Loss (Gain) From Sale of Assets | -18.9 | -18.9 | - | 0.02 | 0.1 | - | Upgrade
|
| Asset Writedown & Restructuring Costs | 3.74 | 3.74 | 0.07 | 0.12 | 0.37 | 0.48 | Upgrade
|
| Loss (Gain) From Sale of Investments | - | - | 0.72 | 0.4 | - | - | Upgrade
|
| Provision & Write-off of Bad Debts | - | - | -0.27 | 0.52 | 1.73 | -0.51 | Upgrade
|
| Other Operating Activities | 29.64 | 22.88 | 16.11 | 15.23 | 17.52 | 17.95 | Upgrade
|
| Change in Accounts Receivable | -38.03 | -38.03 | 7 | -20.18 | -8.45 | 37.47 | Upgrade
|
| Change in Inventory | 35.8 | 35.8 | -1.2 | -66.75 | -40.35 | 7.69 | Upgrade
|
| Change in Accounts Payable | -10 | -10 | -52.08 | 1.79 | 25.94 | 20 | Upgrade
|
| Change in Other Net Operating Assets | - | - | - | - | - | 1.6 | Upgrade
|
| Operating Cash Flow | 83.51 | 88.13 | 77.78 | 75.82 | 124.3 | 175.77 | Upgrade
|
| Operating Cash Flow Growth | -15.39% | 13.30% | 2.59% | -39.00% | -29.28% | 421.13% | Upgrade
|
| Capital Expenditures | -59.34 | -61.45 | -101.7 | -129.2 | -105.69 | -68.15 | Upgrade
|
| Sale of Property, Plant & Equipment | 15 | 15.08 | 5 | 0.03 | 0.08 | 1.35 | Upgrade
|
| Investment in Securities | 0 | 0 | 0 | 50 | -112 | -259.87 | Upgrade
|
| Investing Cash Flow | -44.34 | -46.37 | -96.7 | -79.17 | -217.61 | -326.67 | Upgrade
|
| Long-Term Debt Issued | - | 680 | 506 | 347 | 273 | 568.3 | Upgrade
|
| Total Debt Issued | 681 | 680 | 506 | 347 | 273 | 568.3 | Upgrade
|
| Long-Term Debt Repaid | - | -577.29 | -404 | -278 | -418.63 | -236.99 | Upgrade
|
| Total Debt Repaid | -700.39 | -577.29 | -404 | -278 | -418.63 | -236.99 | Upgrade
|
| Net Debt Issued (Repaid) | -19.39 | 102.71 | 102 | 69 | -145.63 | 331.31 | Upgrade
|
| Issuance of Common Stock | - | - | - | - | 27.81 | - | Upgrade
|
| Repurchase of Common Stock | - | - | -2.99 | -3.1 | -15.02 | -2.7 | Upgrade
|
| Common Dividends Paid | -44.5 | -35.06 | -42.53 | -34.35 | -30.33 | -26.23 | Upgrade
|
| Other Financing Activities | -16.12 | -129.48 | - | - | -1.12 | -3.05 | Upgrade
|
| Financing Cash Flow | -80.02 | -61.83 | 56.48 | 31.54 | -164.3 | 299.33 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | - | 0 | - | - | - | Upgrade
|
| Net Cash Flow | -40.85 | -20.07 | 37.57 | 28.19 | -257.61 | 148.43 | Upgrade
|
| Free Cash Flow | 24.17 | 26.68 | -23.92 | -53.38 | 18.61 | 107.62 | Upgrade
|
| Free Cash Flow Growth | 35.94% | - | - | - | -82.71% | - | Upgrade
|
| Free Cash Flow Margin | 2.77% | 3.11% | -2.51% | -4.91% | 1.92% | 14.33% | Upgrade
|
| Free Cash Flow Per Share | 0.11 | 0.12 | -0.10 | -0.22 | 0.08 | 0.45 | Upgrade
|
| Cash Income Tax Paid | 85.28 | 79.86 | 97.63 | 117.84 | 112 | 86 | Upgrade
|
| Levered Free Cash Flow | -7.34 | 10.05 | -36.93 | -97.92 | -17.28 | 62 | Upgrade
|
| Unlevered Free Cash Flow | -7.34 | 10.05 | -29.55 | -91.24 | -6.9 | 65.42 | Upgrade
|
| Change in Net Working Capital | 20.69 | 9.37 | 7.84 | 70.49 | 5.82 | -58.34 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.